XLP

----

Weekly Recap | Colgate -2.09%, consensus target above spot

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Colgate-Palmolive (CL) closed the week at $84.26, down 2.09% and trailing the S&P 500 by about 1.82 percentage points. The path was front-loaded: the stock rose on Monday and Tuesday, touched a weekly high of $87.215 on Wednesday, then faded into Friday’s low of $83.99 and ended near the bottom of the range. Weekly amplitude came to 3.77%, a clear fade after the early push.

The Week

Colgate-Palmolive (CL) closed the week at $84.26, down 2.09% and trailing the S&P 500 by about 1.82 percentage points. The path was front-loaded: the stock rose on Monday and Tuesday, touched a weekly high of $87.215 on Wednesday, then faded into Friday’s low of $83.99 and ended near the bottom of the range. Weekly amplitude came to 3.77%, a clear fade after the early push.

Key Events

Colgate-Palmolive itself put out little direct news this week, with the key item centred on its dividend. On Tuesday evening, a report noted that the company’s dividend policy was reaffirmed as the fair-value debate came into focus. Earlier that day, two industry-level stories covered cross-sector M&A and strategic partnerships, underscoring that deal activity keeps spreading into niche segments. Read together, the week read more like a renewal of CL’s steady-dividend label than a fresh operating signal. There were no material company filings after routine noise was removed.

Analyst Ratings

Coverage on CL stands at 21 institutions: 7 rate it buy, 6 rate it overweight and 8 rate it hold, with no underweight or sell calls. The consensus recommendation is buy, with a consensus target of $98.60, implying roughly 17.02% upside from spot. Targets range from $87 to $110, showing disagreement mainly about the pace of future growth. Within its household cleaning products peer group, CL ranks 3rd out of 12, putting it near the front of the pack.

The Week Ahead

The US releases final services PMI and ISM non-manufacturing PMI for September early next week, followed by trade balance updates. For a defensive consumer name carrying a rich valuation, services sentiment and trade data could matter more than any single company headline. Company-specific, Colgate’s fiscal Q3 2026 results are set for 30 October pre-market, the next real check on fundamentals.

In Short

This week CL underperformed the market while the ratings picture stayed heavily tilted positive, with the consensus target sitting about 17% above spot. At the same time, the latest capital-flow snapshot shows large-lot money on the sell side and smaller lots absorbing, a split tape. Valuation adds another layer of tension: roughly 33x P/E, an extreme 284x P/B, and just a 2.49% dividend yield sit awkwardly against the defensive label. The key follow-through is whether the late-October earnings print can support margins and volume growth, and whether next week’s macro data shifts the services and trade outlook.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock2,113characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.